Email This Article

Headlines & Perspectives
Merck-Gilead Drug Duel Is Heating Up
By Adam Feuerstein
02/23/07 - 08:17 AM EST
The focus is on safety, tolerability at a big medical meeting.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.00 1,107.93 2,201.05 36.03
Oil *
72.08
DOWN
49.05
DOWN
6.18
DOWN
11.05
UP
0.57
10 Yr
3.60%
SPDR Gold
110.21
-0.47%
-0.55%
-0.50%
+1.61%
Data delayed 20 minutes

Brokerage Partners